Soleil Securities Maintains a 'Buy' on Universal Health Services (UHS); Raises PT & Estimates
Soleil Securities maintains a 'Buy' on Universal Health Services (NYSE: UHS), raises price target from $70 to $79.
Soleil analyst says, "After the market close yesterday, UHS posted Q3 adjusted EPS of $1.03, which was $0.16 above consensus and $0.19 ahead of our estimate. Year-over-year, adjusted EPS increased 41% from $0.73. Results were ahead of expectations on both the revenue ($52.1 million ahead of our estimate) and EBITDA margin (70 bps better than our estimate) lines. EBITDA increased 16.7% YTY and was $13.2 million ahead of our estimate coming in at $153.1 million. UHS raised its fiscal-year 2009 diluted EPS guidance from a range of $4.40-$4.55 to a range of $4.65-$4.80. We are increasing our EPS estimate for 2009 to $4.80 from $4.57 previously. For 2010, we are raising our estimate to $5.25 from $5.00 previously."
To see more analyst ratings on UHS Click Here.
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers.
Related Categories
Analyst CommentsStocks Mentioned
Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
